Brief: TScan Therapeutics Reports Third Quarter 2021 Financial Results
10/11/2021 12:23
Nov 10 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT COMPANY PROGRESS
* Q3 LOSS PER SHARE $0.80
Source text for Eikon: ID:nGNXbvjnPc
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing